Startseite>>Signaling Pathways>> Neuroscience>> Seizure Disorders>>5-hydroxy-Nω-methyl Tryptamine (oxalate)

5-hydroxy-Nω-methyl Tryptamine (oxalate) (Synonyms: N-methyl-5-HT, N-methyl Serotonin, N-methyl-5-hydroxy Tryptamine)

Katalog-Nr.GC42553

5-hydroxy-Nω-methyl Tryptamine is a metabolite of serotonin in humans that has also been found in plants.

Products are for research use only. Not for human use. We do not sell to patients.

5-hydroxy-Nω-methyl Tryptamine (oxalate) Chemische Struktur

Cas No.: 15558-50-6

Größe Preis Lagerbestand
50mg
111,00 $
Please Inquire
100mg
213,00 $
Please Inquire
250mg
473,00 $
Please Inquire
500mg
836,00 $
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

5-hydroxy-Nω-methyl Tryptamine is a metabolite of serotonin in humans that has also been found in plants. It is an agonist of the 5-HT receptor subtype 5-HT7 (IC50 = 23 pM in a radioligand binding assay). 5-hydroxy-Nω-methyl Tryptamine increases intracellular cyclic AMP production in HEK293 cells expressing 5-HT7 (EC50 = 22 nM). It inhibits serotonin uptake in HEK293 cells expressing human serotonin transporters (IC50 = 490 nM). Elevated levels of urinary 5-hydroxy-Nω-methyl tryptamine have been found in patients with schizophrenia, depression, and epilepsy.

Bewertungen

Review for 5-hydroxy-Nω-methyl Tryptamine (oxalate)

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5-hydroxy-Nω-methyl Tryptamine (oxalate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.